Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine add-on study in inflammatory bowel disease patients with depression or anxiety
ChiCTR1900021496Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of venlafaxine in inflammatory bowel disease (IBD), major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Harvey Bradshaw Index, Crohn's Disease Activity Index and 2 more. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
inflammatory bowel disease (IBD)major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on ChiCTR1900021496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021496.